Paper41300764
The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.
Kobayashi N and 6 others. Genes (Basel), 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications. Papers, record 41300764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300764
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| MicroRNAs | Major topic |
| Lung Neoplasms | Major topic |
| Humans | |
| Epithelial-Mesenchymal Transition | |
| Biomarkers, Tumor | |
| Zinc Finger E-box-Binding Homeobox 1 | |
| Gene Expression Regulation, Neoplastic | |
| Zinc Finger E-box Binding Homeobox 2 |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36140280 | Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics. | Biomedicines | 2022 | https://conductscience.org/library/papers/36140280 | PubMed |
| 2 | 39766891 | The Impact of Bevacizumab and miR200c on EMT and EGFR-TKI Resistance in EGFR-Mutant Lung Cancer Organoids. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39766891 | PubMed |
| 3 | 27917453 | Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. | Invest New Drugs | 2017 | https://conductscience.org/library/papers/27917453 | PubMed |
| 4 | 28870611 | Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. | Lancet Oncol | 2017 | https://conductscience.org/library/papers/28870611 | PubMed |
| 5 | 32238921 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. | Br J Cancer | 2020 | https://conductscience.org/library/papers/32238921 | PubMed |
| 6 | 31275609 | Combinatorial perturbation analysis reveals divergent regulations of mesenchymal genes during epithelial-to-mesenchymal transition. | NPJ Syst Biol Appl | 2019 | https://conductscience.org/library/papers/31275609 | PubMed |
| 7 | 28084458 | Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features. | Sci Rep | 2017 | https://conductscience.org/library/papers/28084458 | PubMed |
| 8 | 18485877 | The epithelial-mesenchymal transition generates cells with properties of stem cells. | Cell | 2008 | https://conductscience.org/library/papers/18485877 | PubMed |
| 9 | 18292307 | Selective blockade of microRNA processing by Lin28. | Science | 2008 | https://conductscience.org/library/papers/18292307 | PubMed |
| 10 | 20696752 | Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. | Mol Cancer Res | 2010 | https://conductscience.org/library/papers/20696752 | PubMed |
| 11 | 29634943 | T Cell Dysfunction in Cancer. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29634943 | PubMed |
| 12 | 29792572 | GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics. | Nucleic Acid Ther | 2018 | https://conductscience.org/library/papers/29792572 | PubMed |
| 13 | 26851185 | Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/26851185 | PubMed |
| 14 | 20847327 | The microRNA spectrum in 12 body fluids. | Clin Chem | 2010 | https://conductscience.org/library/papers/20847327 | PubMed |
| 15 | 29874593 | Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28. | Cell Rep | 2018 | https://conductscience.org/library/papers/29874593 | PubMed |
| 16 | 34136077 | Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein-RNA Interaction of LIN28 and Let-7. | ACS Med Chem Lett | 2021 | https://conductscience.org/library/papers/34136077 | PubMed |
| 17 | 37589246 | Pharmacokinetics and Pharmacodynamics of GalNAc-Conjugated siRNAs. | J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/37589246 | PubMed |
| 18 | 21874049 | Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. | Oncogene | 2012 | https://conductscience.org/library/papers/21874049 | PubMed |
| 19 | 34884985 | The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34884985 | PubMed |
| 20 | 25348003 | Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. | Nat Commun | 2014 | https://conductscience.org/library/papers/25348003 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909957 | Beyond immune surveillance: IFN-γ and PD-L1 as shapers of tumor plasticity in Non-Small Cell Lung Cancer (NSCLC). | Front Immunol | 2026 | https://conductscience.org/library/papers/42909957 | PubMed |
| 42882453 | OVO-like Proteins in Cancer, Immunity, and Inflammation. | Cells | 2026 | https://conductscience.org/library/papers/42882453 | PubMed |
| 42652120 | Identification of a CSC-Associated miRNA Signature in NSCLC and Functional Characterization of hsa-let-7a-3p. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652120 | PubMed |
| 42615693 | Exosomes and lung cancer: Biogenesis, pathogenic mechanisms, biomarkers, and therapeutic applications. | J Int Med Res | 2026 | https://conductscience.org/library/papers/42615693 | PubMed |
| 42352916 | A Multi-Level miRNA Regulatory Network Associated with IRF1 Expression in Non-Small Cell Lung Cancer: In Silico Identification of Candidate Biomarkers for Immunotherapy Response. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42352916 | PubMed |
| 42338902 | Comparable Efficacy of Chitosan/miR-200b-3p and Lipofectamine/miR-200b-3p Delivered by Pluronic F127 Hydrogel to Facilitate Diabetic Wound Healing. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42338902 | PubMed |
| 41882712 | MicroRNA-regulated signaling and tumor microenvironment modulation in lung cancer: mechanistic insights and translational opportunities. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/41882712 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| ZEB1 | 6935 | PubTator's text mining | https://conductscience.org/library/genes/6935 | NCBI Gene |
| ZEB2 | 9839 | PubTator's text mining | https://conductscience.org/library/genes/9839 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41300764
GET https://conductscience.org/api/papers/v1/41300764/references?page=2